Purigen Biosystems
Steve Reichenbach has extensive experience in the financial sector. Steve began their career in 1985 as an Audit Senior at Ernst & Young. In 1992, they became the Chief Financial Officer at Flow International. Steve then moved to Applied Precision in 2008, where they held the same role. In 2011, they became the Site Leader at GE Healthcare. In 2015, they became the Chief Financial Officer at Precision NanoSystems Inc. In 2016, they took on the role of Consulting Chief Financial Officer at Purigen Biosystems. Finally, in 2021, they became the Chief Financial Officer at RareCyte, Inc.
Steve Reichenbach attended the University of Washington from 1980 to 1985, where they obtained a BA in Business Administration with a focus on Accounting.
This person is not in any teams
This person is not in any offices
Purigen Biosystems
Purigen Biosystems is revolutionizing DNA and RNA extraction, isolation, purification for life science, cancer, oncology research with its novel charge-based extraction technology.